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Abstract
Background—In 2009, enhanced poliovirus surveillance was established in polio-endemic areas 
of Uttar Pradesh and Bihar, India, to assess poliovirus infection in older individuals.
Methods—In Uttar Pradesh, stool specimens from asymptomatic household and neighborhood 
contacts of patients with laboratory-confirmed polio were tested for polioviruses. In Bihar, in 
community-based surveillance, children and adults from 250 randomly selected households in the 
Kosi River area provided stool and pharyngeal swab samples that were tested for polioviruses. A 
descriptive analysis of surveillance data was performed.
Results—In Uttar Pradesh, 89 of 1842 healthy contacts of case patients with polio (4.8%) were 
shedding wild poliovirus (WPV); 54 of 85 (63.5%) were ≥5 years of age. Shedding was 
significantly higher in index households than in neighborhood households (P < .05). In Bihar, 11 
of 451 healthy persons (2.4%) were shedding WPV in their stool; 6 of 11 (54.5%) were ≥5 years 
of age. Mean viral titer was similar in older and younger children.
Conclusions—A high proportion of persons ≥5 years of age were asymptomatically shedding 
polioviruses. These findings provide indirect evidence that older individuals could have 
contributed to community transmission of WPV in India. Polio vaccination campaigns generally 
target children <5 years of age. Expanding this target age group in polio-endemic areas could 
accelerate polio eradication.
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In 1988, the World Health Assembly resolved to eradicate polio worldwide [1]. In that year, 
the estimated number of paralytic cases was 350 000 in 125 countries. In 2009 there were 
<2000 cases of paralytic polio detected worldwide, and in 2012 only 217 cases were 
reported from the 3 remaining polio-endemic countries (Nigeria, Pakistan, and Afghanistan); 
an additional 5 cases were detected in Chad, the last remaining country with reestablished 
wild poliovirus (WPV) transmission, and 1 case, imported from Nigeria, was detected in 
Niger [2, 3]. WPV has 3 serotypes (1, 2, and 3). WPV2 has been successfully eradicated, 
with the last cases reported in 1999 [4]. In 2012, 88% of all reported cases of paralytic polio 
were due to WPV1 [2].
India was a polio-endemic country until 2011, with the last paralytic case of polio detected 
in January 2011 [2, 5]. This remarkable success is attributed to the Government of India and 
their local and international partners, who have been investing significant human and 
financial resources into polio eradication for many years. The main strategies of the India 
polio eradication program have been to focus on high-quality supplemental immunization 
activities (SIAs) targeting children from birth to 5 years of age with oral poliovirus vaccine 
(OPV), a highly developed social mobilization strategy and approach to reach millions of 
migrants with SIAs, a well-performing acute flaccid paralysis (AFP) surveillance system, 
and strengthening of routine immunization.
Prior to the successful elimination of the last foci of WPV transmission in 2011, India had 
prolonged low-level WPV circulation, as well as occasional outbreaks of both WPV1 and 
WPV3 concentrated mainly in the northern states of Uttar Pradesh and Bihar [6–12]. The 
introduction, in 2005, of more-efficient monovalent and, later, bivalent OPV vaccines into 
SIAs was considered to be the main innovation leading to successful eradication of WPV 
from India [13–15]. During 2005–2011, SIAs were conducted practically every month in the 
high-risk areas of western Uttar Pradesh and Bihar; despite the high quality of these SIAs, it 
took >6 years of intense efforts and enormous resources to rid India of WPV.
The strategy to target children <5 years of age in SIAs was first successfully implemented in 
the Americas in the 1980s and was later adopted in other regions [16]. This strategy is based 
on empirical data of the age distribution of paralytic cases and the assumption that older 
children and adults are mostly immune to infection. Older individuals who do get infected 
are mostly asymptomatic, and they are also assumed to have limited ability to transmit virus 
to others, because of behavioral factors, such as good personal hygiene, because of a shorter 
duration and lower load of poliovirus shedding in stool, compared with younger individuals 
[17–26]. The operating premise of the global polio eradication program is that interrupting 
transmission in young children is sufficient to achieve poliovirus eradication. While the 
obvious success of eliminating poliovirus circulation in India supports this strategy, it does 
not address whether alternative approaches would have achieved the same goal more 
quickly and, possibly, more cost-effectively [16].
Mach et al. Page 2
J Infect Dis. Author manuscript; available in PMC 2015 November 30.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
In India in 2009, however, the assumption that immunizing only children <5 years of age 
would lead to polio eradication was questioned because disease due to WPV was being 
detected in older individuals (from 2004 to 2009, 4.2% of cases of paralytic poliomyelitis 
[127/3050] were reported in individuals ≥5 years of age) and because WPVs of Indian origin 
were exported to other countries on multiple occasions (ie, Angola in 2005 or Nepal in 
2008), suggesting that adult travelers contributed to these outbreaks [27–29]. In addition, 
multiple serological studies from India showed that a very high proportion of young children 
were seropositive for poliovirus and therefore protected against polio, particularly against 
disease due to WPV1 (>98%), and yet low-level circulation of WPV1 continued [15].
Reinfection and shedding of infectious virus in immune individuals has been well 
documented, as has the fact that enteric mucosal immunity wanes with time [30, 31]. 
Although young children who are routinely targeted by SIAs have the opportunity to have 
their mucosal immunity boosted, those outside the target age group will lose mucosal 
immunity over time. Because these individuals represent the majority of the population, 
even small individual contributions to virus shedding could, in aggregate, contribute to virus 
circulation. The relative contribution of different age groups and different immunity status to 
virus circulation remains very difficult to measure.
In response to the persistence of WPV transmission in northern India, enhanced surveillance 
for WPV was temporarily set up in 2009 in the 2 Indian regions where the incidence of 
poliovirus infection was greatest, western Uttar Pradesh and the Kosi river area of Bihar, to 
assess the potential role of older individuals in WPV circulation by measuring the rate of 
WPV shedding in different target populations. The surveillance data from Uttar Pradesh 
were obtained from investigations of household and close neighborhood contacts of patients 
with confirmed poliomyelitis (Uttar Pradesh Contact Surveillance); the data from Bihar were 
obtained from community surveillance (Bihar Community Surveillance). This report 
summarizes the epidemiologic and virologic data from the enhanced surveillance.
METHODS
Uttar Pradesh Contact Surveillance
Stool specimens were collected from asymptomatic contacts of case patients with 
laboratory-confirmed polio (index cases) and tested for the presence of polioviruses in 18 
high-risk districts in western Uttar Pradesh during the high transmission season of 2009 (1 
June–31 October). The total population of these 18 districts is estimated to be 42 million.
A contact was defined as a person of any age without polio-related symptoms who resided in 
physical proximity to the index case. Two types of contacts were sampled: household 
contacts in the index households and neighborhood contacts from households near the index 
household (a typical settlement in rural western Uttar Pradesh consists of a cluster of houses 
surrounded by fields).
We defined a household as a group of people sharing the same kitchen area. Most families in 
rural and urban areas of western Uttar Pradesh live in walled compounds, often sharing a 
common space with other families but having their own food preparation area. An index 
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household was defined as a household where a confirmed polio case patient resided. A 
neighborhood household was defined as a household within the same village as the index 
household; in some cases, this was within the same cluster of houses but did not involve 
sharing the same kitchen.
In index households, up to a maximum of 10 individuals irrespective of age were asked to 
provide 1 stool sample. In neighborhood households, a total of 28 persons were selected at 
random from multiple households and were also asked to provide 1 stool sample. The 
contacts from neighborhood households were selected on the basis of their age and included 
4 children 0–4 years of age and 8 persons each from the following age groups: 5–9, 10–14, 
and ≥15 years. To increase variability, a maximum of 4 persons were selected from a single 
neighborhood household. The selection of neighborhood households was done in concentric 
circles around the index household until a sufficient number of contacts were identified. The 
distance in meters between the index and neighborhood households was estimated by 
enumerators, using subjective observation. A brief questionnaire on demographic 
characteristics and vaccination history was administered to all contacts in index and 
neighborhood households. The collection of contact samples was performed as soon as 
possible after confirmation of the index case.
Bihar Community Surveillance
From 12 April to 15 June 2009, 7 WPV1-associated cases of paralytic polio were reported in 
young and fully immunized children from a small geographic area (referred to as the 
“Surveillance Zone;” Figure 1) spanning a radius of approximately 15 km within 3 blocks of 
Saharsa district (Mahishi, Salkhua, and Simri Bakht) inside or near the Kosi river area 
embankment (blocks in India denote subdivisions of districts). The Surveillance Zone is a 
rural flood plain area with a largely homogenous, well-defined village population that had 
limited mobility because of a lack of infrastructure, except during the annual flooding 
season, when a large proportion of this population migrates to higher ground. The total 
population of the Surveillance Zone is estimated to be 120 000.
By using simple random sampling, 250 households were selected within the Surveillance 
Zone. The list of households was available through polio campaign microplans prepared by 
the polio eradication program. These lists capture the vast majority of households and are 
updated monthly. In each household, 1 child ≤15 years of age and 1 adult >15 years of age 
were selected at random.
A brief questionnaire was administered that focused on demographic characteristics, self-
reported vaccination history, and travel history. From each person, 2 collections of stool and 
pharyngeal swab samples were performed, and samples were tested for polioviruses during 
cycle I and cycle II with an interval of 1 week. Cycle I took place during 13–15 July 2009, 
and cycle II occurred during 20–22 July 2009, the end of season in which poliovirus 
transmission was in Bihar.
Laboratory Testing and Data Analysis
In both enhanced surveillance projects, descriptive analysis of the data obtained was 
performed. Stools and pharyngeal swab samples were tested for the presence of polioviruses 
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in the poliovirus-testing-accredited reference laboratories in India, and, if positive, genetic 
sequencing was performed and viral titer was calculated in the polio reference laboratory in 
Mumbai [32, 33]. Excel and EPI Info software were used to analyze the data.
RESULTS
Uttar Pradesh Contact Surveillance
From 1 June to 31 October 2009, 21 WPV1-associated and 442 WPV3-associated paralytic 
polio cases were detected in 18 high-risk districts of Uttar Pradesh. Contact sampling was 
performed around 21/21 (100%) WPV1 cases and around 33 of 442 (7.5%) WPV3 cases. 
During these investigations, 2084 asymptomatic contacts living in 585 households were 
included (54 were index households and 531 were neighborhood households). The number 
of investigations around the WPV3 cases was limited because of concurrent resource 
mobilization needed for response to an ongoing WPV3 outbreak.
Among the 2084 asymptomatic contacts, 1842 (88.4%) provided adequate stool samples in 
good condition and were tested for the presence of WPV. The remaining 242 contacts did 
not provide stool samples in sufficient volume for testing.
In 54 index households, stool samples were collected from 368 contacts. An average of 6.8 
samples were collected from each index household. The median age of contacts in the index 
households was 18 years, and the range was 2 months to 75 years; 50.8% were female 
(Table 1).
In 531 neighborhood households, stool samples were collected from 1716 contacts. Samples 
were collected from an average of 3.2 contacts in each neighborhood household. The median 
age of contacts in neighborhood households was 11 years, and the range was 1 month to 90 
years; 47% were female. (Table 1)
In 63 of 585 households (10.8%), at least 1 healthy person was shedding WPV. Households 
with at least 1 asymptomatic WPV shedder were significantly more prevalent among index 
households (38.9%) than among neighborhood households (7.9%; P < .05). This association 
remained significant when adjusted for the number of stool samples collected in each 
household (P < .05). In 16 of 585 households (2.7%), >1 person was found to be shedding 
WPV. The maximum number of WPV shedders per household was 5; the mean was 1.4.
In total, 89 of 1842 contacts (4.8%) had WPV-positive stool samples. Of these, 20 were 
WPV1 positive and collected around WPV1 index cases, 65 were WPV3 positive and 
collected around WPV3 index cases, and 4 were WPV3 positive and collected around 
WPV1 index cases. The latter 4 WPV3-positive samples were found in a single household 
adjacent to a WPV1 index case and were removed from further analysis because the link to 
the WPV1 index case was coincidental (Table 2).
In our sample, 54 of 85 shedders (63.5%) were older than 5 years. However, the rate of 
shedding was highest in individuals <5 years old and decreased with increasing age for both 
WPV1 and WPV3 in both index and neighborhood households (Table 2). The median age of 
WPV shedders was 6 years and 2 months (interquartile range, 3–11 years). In index 
Mach et al. Page 5
J Infect Dis. Author manuscript; available in PMC 2015 November 30.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
households contacts were selected at random, and in neighborhood households they were 
selected on the basis of their age. However, the proportion of shedders aged >5 years in 
index households (22/34; 64.7%) and neighborhood households (32/51; 62.7%) was similar.
We did not observe significant differences in vaccination history with OPV between those 
found to be shedding WPV and those who were not shedding WPV. Among those who 
knew their vaccination histories (863; 41.4%), the average number of self-reported doses of 
OPV received was 19, and the proportion of those reporting receiving >3 OPV doses was 
96.8%.
The mean distance between index households and neighborhood households was 20 m for 
households where no shedders were found and 16 m for households where shedders were 
found; the difference in distance was not statistically significant (P > .05). The range of 
distance was 0–250 m.
The median number of days between onset of paralysis of index cases and stool collection in 
contacts was 21 (range, 1–48 days) for index households and 25 (range, 16–89 days) for 
neighborhood households. This period was not significantly associated with the probability 
of finding WPV shedders (P > .05).
Bihar Community Surveillance
Of the 250 randomly selected households in the Surveillance Zone of Saharsa district, 138 
were in Mahishi block, 75 were in Salkhua, and 37 were in Simri Bakht. Ten of the 250 
selected households were locked and excluded. In the remaining 240 households, 214 
children ≤15 years of age and 237 adults >15 years of age were randomly selected. From 
these individuals, we collected 800 stool samples (414 in cycle I and 386 in cycle II) and 
843 pharyngeal swab samples (434 in cycle I and 409 in cycle II). Of 800 stools collected, 
799 were in good condition and were analyzed. Of 843 pharyngeal samples collected, 835 
were in good condition and were analyzed (Table 3).
The proportion of males in the adult group was 28.7%, compared with 53.7% among the 
children; a large proportion of the adult male population was seeking temporary work 
outside of the Kosi river area during the sampling period. Every fourth adult responded that 
they had slept outside of their village for at least 1 night in the past 30 days, compared with 
about 1 in 6 children. Most children <5 years of age (93.5%) reported receiving >3 doses of 
oral polio vaccine. Most of the children 5–14 years of age (76.9%) and adults (96.6%) had 
an unknown vaccination history. Hindu religion was reported by 83% of households and 
Muslim religion by 17% of households.
We found 11 WPVs (7 WPV1 and 4 WPV3) in the stool samples. No WPVs were found in 
pharyngeal samples. We found 9 vaccine (Sabin-like) polioviruses in stool samples (3 type 1 
and 6 type 2) and 1 Sabin-like poliovirus type 1 in pharyngeal samples.
The age distribution of those shedding WPV in stool is shown in Table 4. In one household, 
WPV was found in a young child and in an older person. In all other cases, the WPV 
shedders lived in separate households. Six of 7 individuals shedding WPV1 resided within a 
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2-km radius of households with paralytic WPV1 cases reported during April–June 2009 
(Figure 1). Mean viral titers were similar in younger and older age groups (range, 1.6–4.5 
log10 50% cell culture infectious doses/0.1 mL). The sequencing of polioviruses showed 
close genetic proximity of the WPV found through enhanced surveillance to the previously 
detected isolates from patients in Saharsa with paralytic polio. No significant associations 
were found between reported vaccination history, travel history, sex, or religion and WPV 
shedding.
DISCUSSION
The analysis of data from enhanced surveillance in Uttar Pradesh and Bihar demonstrated 
that a high proportion of persons ≥5 years of age were asymptomatically shedding WPV in 
stool. In Uttar Pradesh, the total number of WPV shedders ≥5 years of age was higher than 
the total number of shedders among children <5 years of age. We believe that older 
individuals shed WPV because their intestinal immunity to poliovirus waned while their 
humoral immunity persisted. In these persons, humoral immunity prevented development of 
paralytic disease but failed to prevent intestinal replication and shedding of the poliovirus 
[34–39].
We observed both household transmission of WPV (among contacts in index households) 
and community transmission of WPV (among contacts in neighborhood households) in the 
Uttar Pradesh contact surveillance investigation. It appears that transmission within 
households, as well as community transmission in all ages and over short distances, played 
an important role in WPV circulation in western Uttar Pradesh, where there is high 
population density, crowding, and poor hygiene.
Most of the asymptomatic persons shedding WPV in Bihar were found to reside in the same 
village as previously reported case patients with paralytic polio. The interval from onset of 
paralytic polio cases and collection of stool from an asymptomatic WPV shedder was 1–3 
months; and up to 2 SIAs with OPV were performed during that interval. WPV in Bihar 
remained confined to a small geographical area for an extended period, which suggests that 
conducting SIAs around confirmed WPV cases, perhaps involving older children and young 
adults, might have interrupted WPV circulation faster.
SIAs with OPV vaccine were performed almost on a monthly basis in this part of Bihar in 
2009. We found fewer people shedding vaccine-type polioviruses than WPVs. This finding 
probably reflects a higher force of infection of WPVs than of vaccine polioviruses, as well 
as high immunity to polio-virus in most of the population [40–42].
No difference in load of viral shedding in stools was detected between older and younger 
individuals. However, the ability to interpret data on duration of shedding and viral load was 
limited because only 1 stool specimen was collected from each person in Uttar Pradesh, and 
in Bihar, the number of WPV excretors was low. Pharyngeal shedding of WPV likely did 
not substantially contribute to WPV transmission in Bihar, because we did not find any 
WPV-positive pharyngeal samples; this is consistent with previous studies that documented 
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pharyngeal shedding of polioviruses to be shorter and less frequent than shedding in stool 
[35, 43].
These findings provide indirect evidence that older individuals may have infected others and 
contributed to community transmission of poliovirus and were in part responsible for 
persisting WPV circulation in India. In recent years, vaccinating older individuals in 
outbreaks with epidemiologic evidence of cases in older age groups has become a norm and 
was applied for control of outbreaks in Tajikistan (2010), Republic of Congo (2010–2011), 
Democratic Republic of Congo (2010–2011), and Namibia (2006). Observations from these 
outbreaks suggest that including older children and adults in SIAs led to shortening the 
duration of outbreaks and reduced the number of SIAs needed to control the outbreak 
(World Health Organization, unpublished data, 2012). Expanding the target age groups for 
SIAs in polio-endemic areas with similar conditions as those found in northern India (ie, 
prolonged low-level transmission in highly immune populations), such as select areas of 
northern Nigeria and Pakistan, might accelerate achievement of global polio eradication.
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Figure 1. 
Geographic distribution of wild poliovirus type 1 (WPV1) cases detected from acute flaccid 
paralysis surveillance and asymptomatic WPV1 shedders identified by enhanced 
surveillance, April–July 2009, Bihar, India. The black line denotes the border of the 
surveillance zone; the red dots denote cases of paralytic polio due to WPV1 detected from 
12 April to 15 June 2009 in Saharsa (dates of onset of paralysis are specified in red boxes), 
blue dots denote asymptomatic WPV1 shedders during contact screening (dates of stool 
collection are specified in blue boxes), and grey dots denote randomly selected households 
identified for contact screening in the surveillance zone.
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Table 1
Findings of Enhanced Surveillance in Uttar Pradesh, India: Household Description
Characteristic Index Households, No. (%) Neighborhood Households, No. (%) Total, No. (%)
Households provided samples 54 (9.2) 531 (90.8) 585 (100)
At least 1 sample positive for wild poliovirus 21 (38.9) 42 (7.9) 63 (10.8)
>1 sample positive for poliovirus 8 (14.8) 8 (1.5) 16 (2.7)
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Table 2
Findings of Enhanced Surveillance for Wild Poliovirus in Stool Samples From Asymptomatic Contacts of 
Case Patients With Polio, Uttar Pradesh, India, 1 June–31 October 2009
Variable Contact Investigations Around 
WPV1 Index Cases, Proportion 
(%)
Contact 
Investigations 
Around WPV3 Index 
Cases, Proportion 
(%)
Total, Proportion (%)
Investigations with at least 1 WPV-positive contact/
investigations completed
10/21 (47.6) 25/33(75.8) 35/54 (64.8)
Contacts with WPV in stool/all contacts tested, by neighborhood type
    All households 20/638 (3.1) 65/1204 (5.4) 85/1842 ( 4.6)
    Index households 10/130 (7.7) 24/208 (11.5) 34/338 (10.1)
    Neighborhood households 10/508 (2.0) 41/996 (4.1) 51/1504 (3.4)
WPV-positive contacts/all contacts tested, by age
    <5 y 5/88 (5.7) 26/177 (14.7%) 31/265 (11.7)
    5–15 y 13/323 (4.0) 29/605 (4.8%) 42/928 (4.5)
    >15 y 2/227 (0.9) 10/422 (2.4%) 12/649 (1.8)
WPV-positive contacts in index households/all contacts tested, byage
    <5 y 3/18 (16.7) 9/35 (25.7) 12/53 (22.6)
    5–15 y 7/41 (17.0) 9/62 (14.5) 16/103 (15.5)
    >15 y 0/71 (0) 6/111 (5.4) 6/182 (3.3)
WPV-positive contacts in neighborhood households/all contacts tested, by age
    <5 y 2/70 (2.9) 17/142 (12.0) 19/212 (9.0)
    5–15 y 6/282 (2.1) 20/543 (3.7) 26/825 (3.2)
    >15 y 2/156 (1.3) 4/311 (1.3) 6/467 (1.3)
Abbreviation: WPV, wild poliovirus.
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Table 3
Results of Tests for Polioviruses (PVs) and Nonpoliovirus Enteroviruses in Stool and Pharyngeal Samples 
Obtained During Enhanced Community Surveillance in Bihar, India, July 2009
Pathogen Positive Stool Specimens, No. (%) Positive Pharyngeal Swab Specimens, No. (%)
Poliovirus
Overall 20 (2.5) 1 (0.1)
    WPV1 7 (0.9) 0 (0)
    WPV3 4 (0.5) 0 (0)
    PV1 SL 3 (0.4) 1 (0.1)
    PV2 SL 6 (0.8) 0 (0)
Nonpoliovirus enterovirus 100 (12.5) 5 (0.6)
Total 799 (100) 835 (100)
Abbreviations: SL, Sabin like; WPV, wild poliovirus.
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Table 4
Age Distribution of Persons Observed to Be Shedding Wild Poliovirus (WPV) Types 1 and 3, Community 
Surveillance, Bihar, India, July 2009
Age WPV1 Positive, Proportion (%) WPV3, Proportion (%)
<5 y 3/162 (1.9) 2/162 (1.2)
5–15 y 3/214 (1.4) 2/214 (0.9)
>15 y 1/411 (0.2) 0/411 (0)
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